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The  earliest  experiments  to  suggest  the  existence  of unique  Frspecific  immune 
responses were ones in which two low or intermediate responder mice were crossed to 
produce a high responder (1-3). These were soon followed by more convincing "all or 
none" experiments with antigens such as poly(Glu55Lysa6Phea)n (GI.4b),  1 in which two 
nonresponder strains were crossed to produce an F1 responder (4, 5). In these studies, 
responder  strains  were also  identified  that  were genetic  recombinants between  the 
two nonresponder strains, demonstrating that two separate genetic elements controlled 
the immune response (4-6). Further mapping studies placed both genes within the I 
region  of the  major  histocompatibility  complex  (MHC),  one  in  I-A,  the  other  in 
I-E/C (7).  Subsequently, other forms of gene complementation were found in which 
one  genetic  element  mapped  outside  of the  MHC  (8)  or  in  which  both  genetic 
elements mapped to the I-A subregion (fl-fl complementation)  (6, 9,  10). 
The first evidence that these immune responses involved the recognition of unique 
F1 antigenic determinants came from studies of the mixed lymphocyte reaction  (1 I) 
in which A/J anti-(B6A)F1  T  lymphocyte populations were found to have a  greater 
proliferative response to  (B6A)Fx  stimulators  than  to  B6 stimulators.  This concept 
was extended to gene complementation for soluble antigen responses through the use 
of radiation-induced, bone marrow chimeras (12,  13) and antigen-presentation exper- 
iments (12-14).  The chimera experiments showed that for the proliferative response 
to GI_4b  , both gene products had to be expressed in the same antigen-presenting cell 
and that neither gene had to be present in the responding T  lymphocyte. The antigen- 
presentation  experiments  provided  functional  evidence  that  Ia  antigens  were  the 
structural elements required for GLt  h presentation by confirming the prediction from 
biochemical studies  (15-1 7)  that the Frspecific restriction element was composed of 
an a-chain coded for in the I-E subregion and a fl-chain coded for in the I-A subregion. 
* Supported by grants GM 07205 and AI 14579 from the National Institutes of Health. 
:~ Address reprint requests to Dr. Schwartz, Laboratory of Immunology,  Bldg. 10, Rm. 1  IN3 l 1, National 
Institutes of Health. 
l Abbreviations used in this paper: GAT, poly(Glue'°Ala:~I'yrl°)n;  GL~, poly(Glu~Lys36phe~)n;  MHC, major 
histocompatibility complex; PPD, purified protein derivative of Mycobacterium tuberculosis; TCGF, T cell 
growth factor. 
J. ExP. MEo. © The Rockefeller  University Press • 0022-1007/81/03/0677/17 $1.00  677 
Volume 153  March  1981  677-693 678  FI-SPECIFIC T  CELL CLONES 
Overall, the experiments provided the strongest correlative evidence to date that the 
Ia antigen-bearing molecules are in fact the Ir gene products. 
The  general  model  that  has  emerged  from  these  studies  is  one  in  which  T 
lymphocytes  possess  receptors  for  antigenic  determinants  unique  to  certain  FI  or 
recombinant  strain  MHC  products  expressed on  antigen-presenting cells,  and  that 
recognition of these determinants is essential for T  cell stimulation. Furthermore, the 
model  predicts  that  only  certain  T  lymphocytes in  the  responder  population  will 
possess such receptors, because if every T  cell had receptors for all  MHC products, 
previous studies  (18-21)  would not have been able to demonstrate MHC restriction 
(i.e.,  separate populations of antigen-specific T  cells in Fl mice restricted to only one 
of the parental MHC haplotypes). With the recent development of the technology for 
cloning T  lymphocytes, it has now become possible to test directly the prediction that 
individual T  cells are restricted to recognizing only one restriction element and that 
clones specific for F1  structures  do exist.  FOr alloreactive T  cells it was shown  that 
individual  clones  recognize  either  unique  F1  MHC  determinants  or  determinants 
shared with the allogeneic parent  (22). 
In this paper we show that  for the soluble protein antigen poly(Glu6°Ala3°TyrX°), 
(GAT) three types of T  cell clones can be found in  (A ×  B)Fa  mice, one specific for 
GAT in association with parent A MHC products, one specific for GAT in association 
with parent B MHC products, and one specific for GAT in association with unique 
F1  MHC  products.  Furthermore, we isolate BI0.A(5R)  clones reactive to GI.4, and 
prove at  the  single-cell  level  our  previous conclusion  that  stimulation  requires  F1 
antigen-presenting cells expressing both high responder Ir gene products and the Ia. 7- 
bearing  aE-chain.  Finally,  we  demonstrate  that  a  monoclonal  antibody  directed 
against the flAP.-a~. Ia molecule can completely inhibit the F1 antigen-presenting cell- 
induced GL~ proliferative response of the B 10.A(5R)  clone, although it has no effect 
on  the  response  of a  PPD-specific B10.A(5R)  colony or  a  GAT-speeific  (B10.A  × 
B10)FI  clone,  which  are both  restricted  to recognizing their  antigen  in  association 
with fl^-aA Ia molecules. These results demonstrate that the biological basis of Ir gene 
complementation  is  the  existence of T  cell clones whose  receptors are restricted  to 
recognition of antigen in association with determinants found only on unique F1  (or 
recombinant) Ia molecules on antigen-presenting cells. 
Materials and Methods 
Animals.  Murine  strains  C57BL/10Sn(BI0),  BI0.A/SgSn,  (B10.A  ×  B10)F1,  and 
B 10.A(5R)/SgSn  were purchased from The Jackson Laboratory, Bar Harbor, Maine. B 10.D2/ 
nSnN  mice were purchased  from the  Division  of Research  Services,  National  Institutes of 
Health, Bethesda,  Md.  BI0.RIII./Sg and B10.Q/Sg mice were the progeny of breeding pairs 
kindly provided by Dr. Jack Stimpfling, McLaughlin Research Institute, Great Falls,  Mont. 
The B10.S/Sx mice were the progeny of breeding pairs kindly provided by Dr. David Sachs, 
National Cancer Institute, National Institutes of Health. All F1 strains were bred in our animal 
colony from these B 10 congenic lines. Mice of either sex between 2 and 12 mo of age were used 
for experiments. 
Antigens and Immunization.  GAT and GI~ were purchased from Miles-Yeda  Laboratories, 
Inc., Research Products Division, Elkhart, Ind. The polymers were dissolved in  1% Na2COa in 
saline and then adjusted to pH 7.2 with 1 N HCI. Purified protein derivative of Mycobacterium 
tuberculosis (PPD)  was purchased from Connaught Laboratories, Toronto, Ontario, as a 2-mg/ 
ml solution  in saline. Mice were immunized in the hind foot pads and the base of the tail with 
100/xg of GAT or GL4, in saline emulsified  in complete Freund's adjuvant containing 1 mg/ml 
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Cell Cultures.  T cells from lymph nodes draining the sites of immunization were prepared as 
previously described (23) by passage over nylon-wool columns and cultured in Click's medium 
with  100  #g/ml  of antigen  and  irradiated  (2,000  rad)  spleen cells as  a  source of antigen- 
presenting cells. 
Soft  Agar  Colony Formation.  2  ×  106  cultured  cells were  collected after  3  d  of in  vitro 
stimulation, washed, and distributed in the upper layer of a two-layer soft agar system in 30- 
mm wells, as described previously (23). After 5 d, colonies were picked and expanded in liquid 
culture with the aid of T  cell growth factor (TCGF) derived from 24-h supernatant fluids of 
concanavalin A-stimulated DBA/2 splenocytes (23,  24).  Cloning from these lines was carried 
out by distributing 200 cells in soft agar, as described in detail elsewhere (23). 
Quantitation of Clonal Responses to  Antigen.  T  cells  from  the  colonies were  examined  for 
reactivity in a 6-d proliferation assay using [ZH]thymidine incorporation (23, 25).  103-5 ×  104 
T  cells were cultured in Click's or RPMI-1640 medium plus 10% fetal calf serum and  10-20% 
TCGF with various concentrations of antigens and different sources of irradiated (2,000  rad) 
spleen cells (104-10  s)  in  a  total volume of 100 #1.  After 3  d,  50 be] of culture medium  not 
containing any cells was removed from  each  culture and  replaced with  50-100 #1  of fresh 
medium containing 10-20% TCGF, antigen, and irradiated spleen cells. After an additional 2 
d, the cultures were pulsed with 1/xCi of [aH]thymidine (6.7 Ci/mmol, New England Nuclear, 
Boston, Mass.) in 10 #i of saline and harvested 16-18 h later using a MASH II (Microbiological 
Associates, Walkersville, Md.). Incorporation of thymidine was measured in a/3 scintillation 
counter (Beckman Instruments, Inc., Fullerton, Calif.) with an efficiency of 50-60%. The results 
are expressed as counts per minute (cpm) -4- the standard error of the mean (SEM) for triplicate 
determinations or as  the  difference between  antigen-stimulated and  nonstimulated control 
means  (Acpm)  -+- the square  root  of the sum  of the squares of the  antigen-stimulated and 
nonstimulated SEM. 
Monoclonal Antibodies and Blocking Studies.  A monoclonal anti-Thy 1.2 antibody was purchased 
in ascites form from New England Nuclear. 20 lal was used to treat 108 erythrocyte-lysed  spleen 
cells in 10 ml of Hanks' balanced salt solution containing 5% heat-inactivated fetal calf serum. 
After 30 min at room temperature, the cells were pelleted and resuspended in 4 ml of a  1:3 
dilution of guinea pig complement (previously adsorbed with mouse spleen cells). After 45 rain 
at  37°C,  the cells were again  pelleted, washed  three times with  phosphate-buffered saline, 
suspended in culture medium, and counted. Viability was generally 50-60% compared with 
the starting population. Using this procedure to eliminate T  cells from a  normal spleen cell 
population, we routinely reduced the proliferative response of such cells to concanavalin A by 
90% or more. 
The monoclonal antibody Y-17 has been shown previously to react with the/~^Eb'k"-aE  k'a'p'r 
Ia molecules on  B cells and  macrophages and  to inhibit specifically the T  cell proliferative 
response of GI~ and pigeon cytochrome c-primed lymph node cells and peritoneal exudate T 
lymphocyte-enriched subpopulations (26). In the present studies, a  1% vol/vol final concentra- 
tion of an NH4SO4 cut of an ascites fluid was added to the wells at the beginning of the 6-d 
culture and again at 3 d  with the supplemental feeding. Inhibition was measured relative to 
cultures without Y-17 and is expressed as a percentage according to the following formula: 
(  AcpmwithY-17  ) 
1  Acpm without Y-17  ×  100. 
Results 
GA T-specific T  Cell Colonies from Fa Mice.  In earlier studies from this laboratory on 
the proliferative response to GAT  (27), it was noted that primed T  cells from  (H-2  a 
X  H-2  ~) and (H-2  b X  H-2~)F1 mice consistently gave a  greater response to GAT when 
the antigen was presented on Fz spleen cells than when the antigen was presented on 
high  responder//-2 ~ or H-2  b parental spleen cells. Because  the low responder H-2  ~ 
spleen cell population did not present CAT at all and because mixtures of H-2  b and 
H-2" spleen cells were no better than H-2  b spleen cells alone, the data suggested that 680  Ft-SPECIFIC T  CELL CLONES 
there were some T  lymphocytes recognizing GAT in association with  Fl-specific/- 
region  gene products.  With  the  recent  development of the  technology for cloning 
antigen-specific T  lymphocytes  (28-33),  it  finally became  possible  to  isolate  and 
unequivocally identify such  Ft-specific T  cells, even in  populations  in  which  they 
might represent only a minority of the total antigen-specific lymphocytes. 
(B10.A  ×  B10)F1  mice  were  primed  with  GAT,  the  draining  lymph  node  T 
lymphocytes were restimulated in vitro with GAT, and the cells were cloned in soft 
agar.  14 colonies were picked,  expanded  in  liquid  culture,  and  tested  for antigen 
specificity in a proliferation assay in the presence of B10, B10.A, (B10.A ×  B10)F1, or 
B10 plus B10.A irradiated spleen cells. As shown in Table I, four distinct patterns of 
responsiveness were found. Four of the colonies (numbers  1, 4, 8, and  12) responded 
to GAT in the presence of spleen cells bearing B 10.A MHC gene products [i.e., B 10.A 
and (B10.A ×  BI0)F1], but not in the presence of spleen cells bearing only B10 MHC 
gene products. The failure of B 10 spleen cells to stimulate was not due to a nonspecific 
suppression phenomenon caused by these cells, because a  mixture of equal numbers 
of B10 and B10.A spleen cells elicited as much of a  proliferative response as B10.A 
spleen  cells alone.  Instead,  it  appeared  that  T  cells  from these  four colonies were 
restricted to recognizing GAT only in association with B10.A MHC gene products. 
Six other colonies  (numbers  2,  3,  5,  9,  10,  and  13)  appeared  to have the opposite 
restriction specificity. They responded to GAT in the presence of B 10 and (B10.A × 
B10)F1 spleen cells but  not  B10.A spleen cells.  Again,  mixing experiments did not 
show any nonspecific suppression, suggesting that T  cells from these six colonies were 
restricted to recognizing GAT only in association with B 10 MHC gene products. The 
10 colonies in these two groups represent the expected two subsets ofFa T lymphocytes, 
restricted to recognizing the antigen in association with one of the parental haplotypes, 
which  have  been  identified  in  uncloned  T  cell  populations  by  several  research 
laboratories (18-21). 
The remaining four colonies represent the new subsets revealed by T  cell cloning. 
TABLE  I 
Different Types of MHC Restriction of GAT-specific T Cell Colonies  from (BIO.A  X  BIO)Ft Mice 
Proliferative response (cpm .+ SEM) to GAT with spleen cells from 
Colony  Specificity 
number 
None  BI0.A  BI0  (BI0.A X BI0)FI  BI0.A +  BI0 
1  120 (:t=20)  36,453 (:t:2,664)  83 (=t:6)  37,423 ('+10,961)  34,450 ('+3,836)  Bt0.A 
4  70 ('+20)  36,473 (=t:834)  70 (±5)  48,193 (.+9,068)  36,206 (:t=913)  BIO.A 
8  100 (:t=30)  16,876 ('+844)  76 (± 17)  26,403 ('+5,853)  19,950 (3=3,291)  BI0.A 
12  80 (.+40)  21,090 (±4,738)  110 (.+11)  33,590 ('+3,415)  35,013 ('+3,790)  BI0.A 
2  165 ('+25)  183 ('+16)  41,350 (=1:3,055)  39,986 ('+1,356)  36,533 (±2,254)  BI0 
3  75 (:1=5)  106 (±13)  39,186 ('+1,228)  34,033 ('+5,038)  36,563 (±1,722)  BI0 
5  65 (:1=25)  86 (.+14)  40,060 ('+1,769)  42,040 (±2,483)  36,513 (±l,g31)  BI0 
9  95 (.+5)  110 (.+ 10)  30,240 (.+6,9~6)  26,760 ('+3,569)  29,926 ('+7,271)  BI0 
10  155 ('+55)  160 (± 11)  27,553 ('+5,721)  32,773 ('+3,526)  21,716 ('+5,989)  B 10 
13  170 ('+10)  86 ('+14)  16,243 ('+2,739)  20,456 ('+1,279)  18,566 ('+4,734)  BI0 
6  167 (±25)  183 (=1=29)  133 ('+48)  41,773 ('+2,410)  176 (3=12)  (BI0.A ×  BI0)F~ 
11  105 (:1=5)  156 (:1=17)  143 (±29)  25,430 (.+3,990)  106 (=1=31)  (BI0.A X BI0)Fa 
14  170 ('4"10)  186 (.+20)  103 (.+311)  32,140 (.+6,I89)  200 (.+72)  (BI0.A ×  BI0)F~ 
7  165 (:t:75)  17,496 (±1,790)  18,833 ('+1,912)  30,150 ('+2,91 l)  38,490 (.+1,617)  BI0.A or BI0 
(BI0.A X BI0)Fj mice were immunized with GAT and T  lymphocytes from the draining nodes were stimulated in vitro with GAT and cloned 
in soft agar. 14 coloni~ were picked and expanded in liquid cuhure. 2 ×  104 T  cells from each colony were stimulated with 100 pg/ml of GAT 
in a 6-d thymidine-incorporation  assay (see Materials and Methods) in the pre~ence  of l0  s irradiated (2,000 rad) spleen cells from B10, B 10.A, 
or  (BI0.A X  BI0)FI mice. In  the mixing experiment  (Bt0.A +  B10),  10  ~ spleen cells of each  type  were added.  The restriction specificity 
observed for each colony is listed in the last column. SREDNI, MATIS, LERNER, PAUL, AND SCHWARTZ  681 
Three of the colonies (numbers 6, 11, and 14) appeared to be restricted to recognizing 
GAT in association with unique Fa MHC gene products. Thus, neither the BI0 nor 
the B 10.A parental spleen cell population supported a GAT response by these colonies. 
Furthermore, a mixture of the two parental spleen cell populations was not sufficient. 
Only FI spleen cells were capable of supporting a  GAT response. The fact that  F1 
spleen cells worked, whereas a mixture of B 10 and B 10.A parental spleen cells failed, 
even though both populations contain the same total genetic information, suggests 
that the H-2  b and H-2  ~ gene products must interact within the same cell to generate 
the unique Fx restriction elements that these three colonies recognize. 
The last pattern of responsiveness, which was defined by only one of the 14 colonies 
(number  7),  consisted  of GAT  stimulation  in  the  presence  of all  the  spleen  cell 
populations tested (Table I). This was potentially the most interesting colony, since 
the data suggested that its cells could respond to GAT in association with either B 10.A 
or B 10 MHC gene products; i.e., the T  cells were not restricted. However, in contrast 
to  the  other  colonies,  these  cells  showed  unusual  quantitative  differences  in  the 
magnitude of the GAT stimulation achieved, depending on which spleen cell popu- 
lation was added. Using (B10.A ×  B10)Fa spleen cells as stimulators, the thymidine 
incorporation was 30,000 cpm, whereas addition of either the B10 or B 10.A parental 
spleen cell population alone resulted in  ~60% of that  amount of stimulation.  Fur- 
thermore, mixing the two parental populations gave an additive result. These data 
suggest  that  the  colony is  not  a  clone of cells  with  a  single  receptor capable  of 
recognizing GAT in association with either parental haplotype but rather is a colony 
composed of at least two clones, one specific for GAT in association with BI0.A MHC 
gene products, and one specific for GAT in association with B 10 MHC gene products. 
However, definitive proof of this  conclusion required  recloning to  isolate the  two 
putative subpopulations. 
200 cells from colony 7 were recloned with  105 irradiated  F1  spleen cells over a 
lower agar layer containing  100 #g/ml  of GAT and  25%  vol/vol TCGF.  From six 
similar platings, an average of 187 4" 5 colonies emerged for a  plating efficiency of 
93..5%. 10 of these colonies were picked, expanded in liquid culture with GAT and F1 
spleen cells,  and  tested  for antigen  specificity in  the presence of B10.A,  B10,  and 
(BI0.A ×  B10)F1 spleen cells. As shown in Table II, two patterns of responsiveness 
were found. Three of the clones (7.3, 7.5, and 7.10) were specific for GAT in association 
with  B10.A  MHC  gene  products,  and  the  other  seven  were  specific  for GAT  in 
association with B 10 MHC gene products. None of the clones showed specificity for 
GAT in association with both B10 and B10.A MHC  gene products, which was the 
property of the original colony. Thus, we conclude that the original colony was not a 
clone but instead was composed of two different GAT-specific T  cell populations, one 
restricted to B10.A, the other to B 10 MHC gene products. This demonstration of a 
colony derived  from  more  than  one  antigen-specific cell  illustrates  why  we  have 
previously been cautious in treating the initial colonies in soft agar as true clones (23, 
24).  Before drawing  any  conclusions  from  unusual  results,  it  is  essential  that  the 
population be recloned with high-plating efficiency at least once. 
GI_xk-specific  T  Cell  Clones.  The  immune  response  to  GI_~  is  the  best-studied 
example at the population level for the existence of T cell clones that recognize unique 
F1 (or recombinant) histocompatibility molecules (7). Because of the relative structural 
simplicity of the antigen, only a  few inbred strains of mice respond to its antigenic 682  F~-SPECIFIC T CELL CLONES 
TABLE II 
Recloning at High-Plating Efficiency  of the  (BIO.A  ×  BIO)Ft  T  Cells Specific for GA T in Association 
with B I O.A or B I O MHC Products Reveals  That the Original  Colony Was a Mixture of Two T  Cell 
Clones with Different Restriction  Specificities 
Proliferative response (cpm ±  SEM) to GAT with spleen cells from 
Clone 
number  Specificity 
None  BI0.A  BI0  (B10.A x  BI0)FI  BI0.A +  BI0 
7. I  B 10  200 (:t:45)  283 ('4"  76)  11,350 (±605)  12,986 (~ 1,356)  12,533 (~ 1,254) 
7.2  B 10  75 (±35)  106 (±44)  10,060 (± 1,769)  12,040 (± 1,483)  12,513 (± 1,831) 
7.3  B 10.A  170 (±  30)  16,473 (±834)  70 (4-15)  18,193 (:t: 1,068)  16,200 (±913) 
7.4  B I 0  258 (::1:75)  260 (±22)  13,553 (± 1,721 )  12,060 (± 1,026)  12,848 (+ 1,124) 
7.5  B I 0.A  174 (±40)  11,290 (± 1,730)  212 (±  21 )  13,370 (:1:1,215)  13,942 (± 1,520) 
7.6  B 10  192 (±5 I)  227 (±62)  10,152 (:t: 1,350)  I 1,731 (± 1,320)  10,951  (± 1,610) 
7.7  B 10  217 (± 78)  307 (:1:86)  14,691 (± 1,782)  12,719 (± 1,517)  13,800 (:1:  1,920) 
7.8  B 10  143 (±21 )  270 (± 102)  12,345 (±991 )  13,012 (± 1,253)  14,070 (± 1,315) 
7.9  BI0  183 ('+-47)  124 (±61)  10,795 (::t:1,042)  9,948 (:1:840)  11,068 (±980) 
7.10  BI0.A  220 (±80)  14,273 (±1,126)  180 (±27)  13,575 (+1,096)  13,970 (±1,836) 
200 T  cells from colony  7 of Table I were recloned at high-plating efficiency (93.5%)  and  10 colonies were picked and expanded  in liquid 
culture. In this experiment,  104 T  cells from each clone were stimulated with  100 ,ug/ml of CAT in a 6-d thymidine-incorporation  assay (see 
Materials and Methods)  in the presence of 105 irradiated spleen cells from BI0, BI0.A, or (BI0.A ×  BI0)FI mice. In the mixing experiment 
(BI0.A +  BI0),  l0  s spleen cells of each type were added.  Two types of restriction specificities were found:  seven clones having T  cells that 
recognize CAT in association with BI0 MHC gene products, and three clones having T  cells that recognize GAT in association with BI0.A 
MHC products.  No clones were found having T  cells that had the joint recognition properties of cells from the original colony. 
determinants.  Furthermore, strains  of only one haplotype appear to be capable of 
using solely the/-A-subregion gene products to generate an immune response against 
GI~  (H-2q).  All the other responder strains require gene products in both/-E and 
I-A. Thus, it was possible even before T  cell cloning to demonstrate the need for both 
/-region gene products to be expressed in the same antigen-presenting cell  (12,  13) 
and the requirement for the T  cell population to recognize such Fl-specific histocom- 
patibility structures to generate a  GL~ response  (14).  From these data and special 
experiments with  chimeric  mice  designed  to  exclude two  T  cell  models  (13),  we 
concluded that the existence of clones ofT cells specific for F1 (or recombinant) MHC 
gene products was the only way to explain the results. However, unequivocal proof of 
this  hypothesis required isolation of GL~specific T  cell clones and  demonstration 
that these cells had all the recognition properties of the original T  cell population. 
B 10.A(5R) mice, the GIAb-specific  high responder recombinant strain derived from 
a crossover event between the low responders A/WySn (H-2  ~) and C57BL/10Sn (H- 
2  b) during the derivation of the B 10.A congenic line, were immunized with 100 #g of 
GI.4b. 7 d later, the T  lymphocytes from the draining lymph nodes were prepared and 
stimulated in vitro with 100 #g/ml of GI~. 3 d later 2 ×  106 cells (six replicates) were 
cloned in soft agar in the presence of antigen. After another 5 d, an average of 45 + 
6 colonies were observed, representing a clonal frequency of 2.3 ×  10  -5. This is similar 
to the clonal frequencies we have observed previously for the antigens PPD and the 
dinitrophenyl derivative of ovalbumin (23, 34).  20 of these colonies were picked, nine 
were successfully expanded in liquid culture, and six of them were tested for antigen 
specificity. Cells  from  all  six  colonies were  shown  to  be GI~-specific  using  a  6-d 
proliferation assay (data not shown).  200 cells from one of the colonies (number 6) 
were recloned in soft agar in the presence of antigen but without TCGF (six replicates). 
An average of 173 +  5 colonies appeared after 5 d  for a cloning efficiency of 86.5%. 
10 of these clones were picked, nine of them were successfully expanded in  liquid 
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specific. Finally, to be statistically confident at the 5% level that we were dealing with 
true clones ofT cells, we subcloned again, this time in the presence of 25% TCGF but 
without antigen. From six replicate plates, each seeded with 200 cells of clone 6.2, we 
recovered an average of 183 +  3 colonies for a cloning efficiency of 91.5%.  10 of these 
colonies were picked, all of them were successfully expanded in liquid culture, and 
five were tested and shown to be GL~ specific (some of  the data showing responsiveness 
to GL~ are shown in Tables IV-VII as controls for those experiments). The probability 
that any of these subclones were derived from a single cell, making the most stringent 
possible assumptions, is 
1  --  r 13s  9.5 
L86.5 x 91.5]--0.984) 
(see reference 23 for the mathematical basis of this calculation). 
Having generated a  series of GI.~-specific T  cell clones and  subclones,  we  next 
examined the genetic requirements for antigen presentation by varying the source of 
irradiated spleen cells added in the proliferation assay. As shown in Table III, the T 
cells at all stages of their cloning (colony, clone, subclone) could be stimulated with 
GL0 in the presence of the high responder (B10.A X B10)F1 spleen cells in addition 
to the syngeneic B10.A(5R) spleen cells.  In contrast, they could not be stimulated at 
all in the presence of either the low responder B10 (Ir-Gl_~ a-fl  +) or B10.A (Ir-GI.~ 
t~+fl  -) parental spleen cells. Even more important is that a mixture of B10 and B 10.A 
spleen  cells was  totally nonstimulatory.  This  result  (as  discussed  for GAT earlier) 
demonstrates that both high responder Ir genes must be expressed in the same antigen- 
presenting cell. Overall, the results confirm the findings made with uncloned T  cell 
populations  (12).  In addition, because absolutely no stimulation was seen with the 
low responder parental spleen cells for any of the six independently derived colonies, 
we  can  conclude  that  it  is  likely that  the  small  stimulations  seen  in  the  original 
experiments, which used uncloned T  cells, were due to antigen carryover to residual 
Ft or 5R antigen-presenting cells in the responding T  cell population rather than to 
TABLE III 
Stimulation of GLck-specific B IO.A (5R)  T Cell Clones Requires Spleen Cells from High Responder Mice 
Expressing Both Ir-GLgp Gene Products in the Same Cell* 
Ir-Gl~k 
Antigen-pre-  alleles:~ 
sentlng spleen 
Proliferative response (cpm 4- SEM) to GI.,~ by B10.A(5R) 
cells 
a  fl  Colony  I  Colony 6  Clone 6.2  Clone 6.4  Subclone 6.2.3  Subclone 6.2.4 
None  Nl~  ND  67 (+28)  173 (±52)  160 (±49)  72 (±16) 
BI0.A(5R)  +  +  35,740 (±2,884)  38,846 (±2,547)  7,447 (±61)  9,243 (±1,774)  12,730 (±515)  9,220 (±1,753) 
BI0.A  +  --  90 (±55)  63 (:t:19)  60 (+15)  67 (±15)  I I0 (±15)  87 (±15) 
BI0  -  +  37 (±12)  77 (±12)  70 (±10)  87 (±20)  47 (±9)  67 (±27) 
B10.A +  BI0  ±  4:  203 (:t:168)  85 (±15)  73 (±22)  63 (±23)  73 (±88)  70 (+15) 
(BI0.A ×  BI0)F~  +  +  38,820 (±980)  34,693 (±2,819)  10,177 (±1,492)  9,497 (±1,514)  9,410 (±808)  10,197 (±1,351) 
* BI0.A(5R) mice were immunized with GI~k and T  cells from the draining lymph nodes were isolated and stimulated with GI~ in vitro. After 3 d, the 
cells were cloned in soft agar. Six colonies were picked and expanded in liquid culture. T cells from colony 6 were recloned in soft agar from which five 
clones were isolated and expanded  for testing. One of these clones, 6.2, was recloned again and five subelones were isolated and expanded for testing. 
This table shows results from experiments in which 2 ×  10  + T  cells from colonies 1 and 6, 5 ×  10  s T  cells from clones 6.2 and 6.4, and 5 ×  103 T  cells 
from subclones  6.2.3 and 6.2.4 were stimulated with  100 ,ug/ml of GI,~ in the presence of l0  s irradiated (2,000 rad) spleen cells from  BI0.A(5R), 
BI0.A, BI0, or (BI0.A ×  BI0)FI mice.  In  the mixing experiment,  10  s  B10.A and  10  s  BI0 spleen  cells were added.  Stimulation  was assessed  by 
measuring the incorporation of tritiated thymidine in a 6-d assay as described in the Materials and Methods. 
:~ +  indicates a high responder allele; -  indicates a  low responder allele at either the Ir-Gl~-a or lr-GI.4~/~  locus. 
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clones of T  cells in those populations capable of seeing GI.4b in association with low 
responder B10.A or B10 MHC gene products. 
Recent structural studies on Ia antigens using one- and two-dimensional gels (15- 
17) and peptide mapping (35-37) have provided a potential biochemical basis for the 
functional two-gene complementation. These studies revealed that the 1-E subregion 
encodes only the larger a-chain (a~) of an Ia molecule, whereas a gene in 1-A codes for 
the physically associated, smaller fl-chain (fln~.). The assembly of these two chains to 
form a  functional  molecule  (flAE-aE) can  only occur when  both  gene products  are 
expressed in the same cell. Thus, if one were to equate Ia-bearing molecules with/r 
gene products,  one could  then  predict  that  the flAv.-aw  Ia molecules found  only in 
certain Fz and recombinant strains were the restriction elements on the surface of the 
antigen-presenting cells that were required  for stimulating Gl_.~-primed T  lympho- 
cytes.  In  other  words,  lr  gene  defects  were  simply  the  absence  of  (or  failure  to 
stimulate)  T  cells  capable  of recognizing  particular  antigens  in  association  with 
particular MHC gene products. 
To test this prediction, we examined the genetic requirements at the 1-E subregion 
for  spleen  cells  to  present  GI_~  to  primed  B10.A(5R)  T  lymphocytes  (14).  The 
B 10.A(5R)  strain possesses 1-A b and 1-E  ~ alleles. To examine MHC restriction at the 
1-E subregion only, a  series of F1  mice were bred in which one parent was always a 
B10  (I-A b,  I-Eb).  Thus,  when  spleen  cells  from these  F1  mice were used  to present 
GI~, they all shared 1-A b with the responding B10.A(SR)  T  lymphocytes and only 
varied at 1-E.  The results using uncloned  T  cell populations as responders revealed 
that spleen cells from H-2  b by H-2  ~, H-2  k, H-2 a, H-2 o, or H-2  ~ Fl's were all capable of 
presenting  GI.4b, whereas  spleen  ceils  from H-2  b by H-2  r,  H-2  q,  or H-2  ~ could  not 
present  GIAb  (14).  The results  using  the GL~-specific B10.A(5R)  T  cell  clones  are 
shown  in Table IV. At  all stages of their cloning the specificity of the T  cells was 
identical to that found for the whole population, i.e., they responded to GI.4b in the 
presence of H-~ by H-2  a, H-2  d, or H-Z F1 spleen cells but not in the presence of H-2 b 
by H-2  q, or H-2  ~ F1 spleen cells. In addition, using clones as the responding population 
eliminated the need to derive the GIAb response data by subtracting the MLR-induced 
stimulation, which was always present when uncloned T  cell populations were used 
as responders  (14).  The absence of any alloreactivity by the T  cell clones allowed a 
conclusive demonstration that the H-2  q and H-2  ~ haplotypes could not complement 
at all for GL~ presentation, whereas the H-2  d and H-2  ~ haplotypes could complement. 
Furthermore, the H-2  d and H-Z 1-E alleles appeared to be functionally equivalent to 
the syngeneic H-2  a allele, as judged by the magnitude of the proliferative response. 
These results correlate perfectly with the biochemical studies on the I-E subregion Ia 
antigens in which the aE-chains coded for by the H-2 k, H-2  d, H-2 p, and H-2  ~  haplotypes 
were shown by peptide mapping to be structurally very similar (35-37) and in which 
no aE-chain could be found in spleen cell lysates from H-2  t-, H-2  q-, and H-2~-bearing 
mice (15). Thus, the data demonstrate that the B 10.A(5R) T  cell population contains 
clones of T  cells that were selected on the basis of their ability to recognize GI.4b in 
association with the fl^Eb-av, k molecule on the surface of the antigen-presenting cell 
and that these T  cell clones are capable of responding when any of the other similar 
a~.-chains  are  substituted  for  aE  k.  This  perfect  correlation  between  structure  and 
function  provides  strong  evidence  in  support  of  the  hypothesis  that  Ia-bearing 
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TABLE  IV 
Stimulation of GLc~-specific B I O.A (5R)  T Cell Clones is Supported by Spleen Cells  from (B I O X  B I O.A  ), 
(BIO X  BIO.D2), and (BIO ×  BIO.RIII)Ft Mice but Not from  (BIO X  BIO.Q) and (BIO ×  BIO.S)Ft 
Mice * 
MHC 
Ant igen-pr-~c..,.en  t ing  alleles:~  GL~ 
__ (100 t~g/ 
spleen cells  ml) 
l-d  I-E 
Proliferative response  (cpm ± SEM) to GI~  by BIO.A(SR) 
Colony  1  Colony 6  Clone 6.2  Clone 6.5  Subclone 6.2.1  Subclone 6.2.3 
BI0.A(5R)  b  k  -  ND H  ND  40 (±30)  57 (~19)  120 (~23)  180 (4"37) 
§  +  116,773  (:t:3,879)  136,875 (:1:10,900)  12,597  (4"448)  11,207  (±1,758)  10,530 (:1:1,239)  10,710 (±1,395) 
(BIO × BI0.A)F~  b/k  b/k  -  ND  ND  17 (4"3)  58 (:t:9)  145 (±82)  210 (±87) 
§  +  131,606  (±4,439)  138,766 (4"9,031)  12,513  (±3,188)  9,993  (4"2,002)  7,587  (4'1:380)  8,063  (±700) 
(BIO × BIO.D2)Fa  b/d  b/d  -  ND  ND  13 (4'1:3)  54 (±10)  60 (4-10)  53 (:t:15) 
§  +  126,435  (±4,961)  139,266 (±9,716)  8,183  (±742)  10,087  (+1,446)  10,773 (±715)  10,417  (4"593) 
(BI0 × BI0.RIII)F~  b/r  b/r  -  ND  ND  23 (±3)  67 (±14)  87 (4"42)  83 (±19) 
§  +  113,533  (±2,376)  141,458 (±8,391)  7,997  (4"348)  9,563 (±73)  10,193  (4"603)  10,537  (4"719) 
(BI0 × BI0.Q)F~  b/q  b/q  -  ND  ND  30 (4"10)  126 (±142)  ND  ND 
+  80 (±25)  130 (±17)  53 (±7)  63 (±20)  50 (4"6)  88 (±24) 
(BIO × B10.S)F~  b/s  b/s  -  ND  ND  20 (4"6)  118 (±47)  ND  ND 
+  110 (± 1  I)  106 (±24)  67 (4" 18)  70 (±27)  60 (4" 15)  53 (4"15) 
* GL~ clones were prepared as described  in the legend to Table IIh This table shows the results from experiments  in which 5 ×  104 T cells from colonies 
1 and 6, 5 ×  103 T cells from clones 6.2 and 6.5, and 5 ×  103 T cells from subclones  6.2.1 and 6.Z3 were cultured with or without  100/zg/ml  of GL¢ 
in the presence of 5 ×  l0  n (for the colonies) or 10 ~ (for the clones and subelones)  spleen cells (2,000 rad irradiated)  from BI0.A(5R), (B 10 × BI0.A)F~, 
(B10 X BI0.D2)Fh (BI0 × BI0.RIII)FI,  (Bl0× B 10.Q)FI, or (B 10 X BI0.S)F~ mice. Stimulation was assessed  in a 6-d tritiated thymidine-incorporation 
assay as described  in Materials and Methods. 
:~ Letters refer to the haplotype source of origin of the alleles of the I-A and I-E subregions  of the MHC possessed  by each spleen cell donor. 
§ indicates that these spleen cells bear Ia-specificity  7 and possess  I-E subregion  genes which code for similar aE chains as detected by peptide mapping 
(I-E k, LE d, I-E'). 
[[ Not determined. 
Inhibition  of Clonal  T  Cell Proliferation  with a Monoclonal Antibody.  Recently, a mono- 
clonal  anti-Ia  antibody has  been  described  that  reacts  with  a  determinant  on  the 
fl~a~b'k'r~-av,  k'd'p¢ Ia  molecule  (26).  This  antibody  was  found  to  inhibit  the  T  cell 
proliferative  response of B10.A(5R)  cells primed  to GL~ and B10.A cells primed  to 
pigeon cytochrome c (26), responses that require the fl~a~-aE molecule as a restriction 
element  for antigen presentation  (14, 38).  In contrast,  the antibody did not inhibit 
the T  cell proliferative response of B10.A(5R)  cells primed to (T,G)-A--L, a response 
which  presumably  utilizes  only the flA-aA  Ia  molecule  as  a  restriction  element  for 
antigen  presentation  (39).  Although  experiments  with  radiation-induced  chimeras 
(40)  have unequivocally shown that the antibodies have their effect  on the antigen- 
presenting cell and not the T  cell, the mechanism of this antigen-specific inhibition is 
not clear. It has been postulated that the antibody covers or strips off the relevant Ia- 
bearing  molecules  on  the  surface  of  the  antigen-presenting  cell,  thus  preventing 
antigen  recognition  (39, 41).  However,  the possibility has not been eliminated  that 
the masking  of the Ia antigens somehow  leads  to the development  of suppressor T 
cells,  which  actually mediate  the inhibition  (42).  To  investigate  this possibility  we 
asked  whether the antigen-induced proliferative responses of the T  cell clones could 
also be inhibited with the monoclonal antibody. 
As shown in Table V, the response of the GL~-specific  B10.A(5R)  subclone, 6.2.3, 
was completely  inhibited by the monoclonal antibody Y-17.  In contrast, the prolif- 
erative response of cells from a B 10.A(5R) colony specific for PPD was not significantly 
inhibited by  1% Y-17.  The  failure to inhibit the PPD  response stems  from  the fact 
that these cells are restricted  to recognizing the fl^-aA pair of Ia molecules  encoded 
solely in the I-A  subregion  (data not shown), whereas  the antibody reacts  with the 
flAv.-aE Ia molecule. Because in both responses (GI~ and PPD) there are no suppressor 686  FrSPECIFIC T  CELL CLONES 
TAaLE V 
Inhibition of the Proliferative Response of T Cells from a GI_,ep-specific  B IO.A (5R) Subclone but Not T Cells from 
a PPD-specific Colony by the Monoclonal Antibody  Y-17 
Experiment  1  Experiment 2 
T  cells  Antigen  cpm :1: SEM  Inhibi-  cpm ±  SEM  Inhibi- 
tion  tion 
No Y-17  With  1'~,~ Y-17  No Y-17  With  1% Y-17 
i.tg/ml  '~  ,~ 
Subclone 6.2.3  None  143 (±20)  183 (-*-30)  --  133 (:1:74)  170 (±6)  -- 
GL@specific  GL~ (50)  I 1,513 (±413)  150 (:1:21)  100  10,833 (:1:381)  127 (:1:33)  100 
from BI0.A(5R)  GIAb (100)  10,960 (:1:1,263)  237 (±30)  99.5  10,563 (:1:450)  150 (:1:25)  100 
Colony 3  None  97 (±24)  137 (:1:20)  --  147 (±32)  193 (:1:20)  -- 
PPD-specific  PPD (25)  11,467 (:1:1,079)  10,095 (:1:115)  12.4  11,833 (±982)  11,220 (±546)  5.6 
from BI0.A(5R)  PPD (50)  9.820 (:1:1,059)  12,527 (:1:1,895)  0  11,103 (:1:1,217)  11,267 (:1:444)  0 
5 X  10  a T  cells from either the GI~specil]c  BI0.A(5R) subclone 6.2.3 or the PPD-specific BI0.A(5R) colony  3 were stimulated with their respective 
antigens and 10  ~ BI0.A(5R) irradiated (2,000 rad) spleen cells in the presence or absence of 1% vol/vol Y-I 7. Stimulation was assessed in a 6-d tritiated 
tbymidine-incorporation  assay. The data are expressed  as counts per  minute  (4-SEM)  and as percent  inhibition  by Y-17, which was calculated  as 
described in Materials and Methods. 
TABLE VI 
Inhibition of the Proliferative Response of T Cells from a GLep-specific B IO.A (5R) Subclone but Not T 
Cells from a GAT-specific (BIO.A  ×  BIO)Ft Clone by the Monoclonal Antibody  Y-17 in the Presence of 
Either BIO.A (5R)- or (BIO.A  ×  BlO)Ft-presenting Cells 
Proliferative response cpm (±SEM) 
T  cells  Spleen cells  Antigen  Inhibition 
No Y-17  With  1~7, Y-17 
I00 ts.g/ml  "/, 
Subclone 6.2.3  B 10.A(5R)  None  127 (± 12)  93 (+ 13)  -- 
GL~ specific  GL~  10,087 (4-512)  803 (±25)  92.8 
from B 10.A(5R)  (B IO.A ×  B IO)Fx  None  90 (± 12)  60 (4-6)  -- 
GI.t~  10,080 (±1,011)  83 (:1:33)  100 
Clone 7.8  B I 0.A(SR)  None  167 (:1:-  12)  57 (± 17) 
GAT specific  CAT  8,682 (:1:191)  10,505 (4-1,184)  0 
from (BI0.A ×  BI0)Fx  (BI0.A ×  BI0)Fx  None  120 (±47)  50 (:1:6)  -- 
GAT  9,270 (±410)  9,490 (4-43)  0 
5 X  10  a T  cells from either the GL~specific B 10.A(5R) subctone 6.2.3 or the GAT-specific (B 10.A x  B 10)Fi clone 7.8 were stimulated with 100 
/xg/ml of their respective antigens in the presence of l0  n B10.A(5R) or (BI0.A X B 10)FI irradiated spleen cells.  Proliferation was assessed in the 
presence or absence of 1% vol/vol Y-17, as described in the legend to Table V. 
cells in the responding population and the antibody is reacting with the same antigen- 
presenting  cell,  it  seems reasonable to conclude that  the antigen-specific  inhibition 
results from masking the relevant restriction element in some manner. 
Further support  for this model  is shown in Table  VI,  in which the ability  of t.he 
GI_~-specific  B10.A(5R)  subclone 6.2.3  to respond to GL~ in the presence of (B10.A 
×  B10)F1  as well as B10.A(5R)  spleen cells was used.  In this experiment,  one of the 
GAT-specific clones (number 7.8) from (B10.A ×  B 10)F1 mice (see Table II) was used 
as a  control. This clone was restricted  to recognizing GAT  in association with only 
I-A b MHC gene products, because it could be stimulated equally well by GAT in the 
presence  of  either  B10  (Table  II)  or  B10.A(5R)  (Table  VI)  spleen  cells.  Y-17 
completely  inhibited  the  GI_~  response  of subclone  6.2.3  in  the  presence  of either 
B10.A(5R)  or (B10.A ×  B10)F1 spleen cells. In contrast, the antibody had no effect on 
the  GAT-induced  proliferation  of clone  7.8  in  the  presence  of either  spleen  cell 
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antigen-specific manner, provided that the two antigens being examined use different 
restriction elements. 
Although these experiments clearly indicate that suppressor T  cells in the respond- 
ing population cannot be the mechanism of anti-Ia antibody-induced suppression of 
T  cell proliferative responses, it was still possible that T  cells in the added spleen cell 
population accounted for the phenomenon. To investigate this possibility we repeated 
the blocking experiments using anti-Thy 1 and complement-treated spleen cells as a 
source of antigen-presenting cells.  As shown in Table VII, this population presented 
GI_~ as well as whole spleen (compare with Table VI, which shows data with whole 
spleen cells from the same experiment), and this presentation was completely inhibited 
by  Y-17.  Thus,  T  cells  in  the  spleen  cell  population  are  not  required  either  for 
presentation  of the  antigen  to  the  clone or  for the  monoclonal antibody Y-17  to 
produce its blocking effect. Overall, these results convincingly demonstrate that anti- 
Ia antibody inhibition is not mediated by suppressor T  cells of any kind. 
Discussion 
The  existence  of T  cells  specific  for antigens  in  association  with  unique  F1  or 
recombinant MHC gene products has been postulated for a number of years on the 
basis of work with whole T  cell population responses to antigens such as GL~ (7,  12- 
14).  In this report we conclusively prove the existence of such T  cells by isolating 
antigen-specific colonies from primed T  cell populations, rigorously cloning the cells 
under conditions of high-plating efficiency, and demonstrating that such clones can 
only  be  stimulated  with  antigen  in  association  with  spleen  cells  bearing  F1  or 
recombinant MHC haplotypes. Neither parental spleen cell population alone nor the 
combination of the two supported a  proliferative response. In  the case of the GI~ 
response  of B10.A(5R)  clones,  it  was  possible  to  identify the  unique  MHC  gene 
products  from  antigen  presentation  (Table IV)  and  anti-Ia  blocking experiments 
(Tables V-VII) as consisting of an Ia.7-bearing a-chain encoded in the I-E subregion 
(aE)  and  a  fl-chain encoded in  the I-A  subregion  (flAE). These results confirm the 
TABLE  VII 
Depletion of T Cells from the Presenting Cell Population Does Not Affect the Ability of the 
Monoclonal Antibody Y-17 to Inhibit the Proliferative Response of T Cells from a GLdp-specific 
B10.A (5R) Subclone 
Proliferative response (Acpm :t: SEM) 
Spleen cells  Gl-4b  Inhibition 
No Y-17  With 1% Y-17 
ttg/ml  % 
B10.A(5R)  50  9,500 (±700)  80 (±16)  99 
100  10,200 (±900)  -10 (±37)  100 
(BI0.A x BIO)F,  50  10,900 (±880)  50 (±50)  99.5 
100  9,300 (±1,300)  90 (+21)  99 
5  ×  103 T  cells from the GL@specific BI0.A(5R)  subclone 6.2.3 were stimulated with 50 or  100 
#g/ml of GI-~ in the presence of 105 irradiated  (2,000 rad)  BI0.A(5R) or (B10.A ×  B10)FI spleen 
cells previously treated with monoclonal anti-Thy 1 plus complement as described in Materials and 
Methods. Proliferation was assessed in the presence or absence of 1% vol/vol Y-17 as described in 
the legend to Table V. The data are expressed as Acpm, the difference between cultures with and 
without antigen, ±SEM, the square root of the sum of the squares of the standard errors of the two 
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conclusions  reached  with  whole  T  cell  populations  (12-14,  26)  that  Gl_~-specific 
B 10.A(5R) T  cell clones have dual specificity for antigen and the flAE-aE Ia molecule. 
In addition, they demonstrate that this restricted recognition mechanism is an intrinsic 
part of the responding T  cell machinery and not  a  secondary result of an extrinsic 
suppressor  mechanism  by  regulatory  T  cells.  Why  GI~  is  obligatorily  linked  to 
recognition of flAE-aE Ia molecules has not been elucidated by these studies. The two 
competing models that explain this phenomenon postulate either that the Ia molecules 
have some primitive form of binding site that discriminates between different antigens 
(43, 44) or the T  cell population lacks certain clones of T  cells, either because of their 
absence from the initial precursor pool or because such clones are deleted in the course 
of development of self tolerance and/or self recognition (45-50). At this time, there is 
no  definitive  evidence  that  would  allow  us  to  decide  between  these  two  general 
models. 
The cloning technology has  also  allowed  us to  generalize the concept  of T  cells 
restricted to unique Fa MHC products by demonstrating that such clones exist even 
in T  cell populations responding to antigens that can be presented by either of the 
parental MHC gene products alone. The Frspecific clones are difficult to detect  in 
such whole-population responses, because they often represent only a  minor subpop- 
ulation  of the  total  responding  cells.  However,  cloning  allows  one  to  isolate  and 
expand even small subsets so that the specificity of the cells can be clearly delineated 
(51).  In this regard it is interesting to note that of the  15  (H-2  a ×  H-2b)Fa colonies 
isolated  that  were  specific  for  GAT  (counting  the  mixed  colony  as  two  separate 
colonies), all of them were MHC restricted in one form or another. 33% of the colonies 
recognized GAT in association with H-2  ~ MHC gene products, 47% recognized GAT 
in association with H-2  b MHC gene products, and 20% recognized GAT in association 
with unique F1 MHC gene products. None of the clones were capable of recognizing 
both H-2  ~ and H-2  b MHC gene products, i.e., none were unrestricted.  Thus, MHC- 
restricted recognition of antigen appears to be the major, if not the sole, form of T  cell 
recognition, at least for the proliferating T  lymphocyte after priming. 
The GAT-specific T  cells restricted to recognizing unique F1 MHC gene products 
showed the same pattern of restriction as the GI~-specific T  cells (compare Tables I 
and III). However, this does not necessarily mean that the T  cells from GAT colonies 
recognize the same Fa structures as the Gl_~-specific T cells. In fact, recently published 
data from the laboratory of C. G. Fathman (33)  suggest that the unique Fa products 
seen by the GAT-speeific T  cells result from fl-fl complementation (7,  10),  in which 
the aA and flA Ia products of the two I-A subregions rearrange to give the/~Ab-~fltA  k and 
flAk-aA  b combinations found only in  the  Fa.  The reason that  GAT recognition uses 
only these mixed molecules, whereas GL~ recognition requires the flAE-aV, molecule, 
is not clear. 
Before T  cell cloning, the concept that MHC restriction was needed for the T  cell 
to recognize self MHC antigens, in addition  to the foreign antigen on the surface of 
antigen-presenting cells, was supported experimentally mainly by inhibition  studies 
with antibodies directed against MHC gene products (39, 52). Although some of these 
studies showed that lymphocyte binding to macrophages (53,  54) could be inhibited 
with  anti-Ia  antibodies,  suggesting  that  T  cell  recognition  was  being  impaired,  a 
recent publication describing experiments in a human system (42) demonstrated that 
the inhibition  might be more complex and might involve the function of suppressor SREDNI, MATIS, LERNER, PAUL, AND SCHWARTZ  689 
T cells. To investigate this possibility in the better-defined murine model, we examined 
the ability of a monoclonal antibody Y- 17 that reacts with the flAE-aE Ia molecule to 
inhibit  the proliferative response of a  Gl-4~-specific  B10.A(5R)  T  cell clone, which 
requires the  presence of the flAZ-aE Ia  molecule on  the  antigen-presenting  cell for 
stimulation.  As  shown  here,  the  monoclonal  antibody  completely  inhibited  the 
proliferative response of the GL~specific clone, even in the total absence of any other 
T  cells to act as suppressor cells. The inhibition was shown to be absolutely specific 
for T  cell clones that  require the flAE-ae  Ia  molecule for stimulation,  because the 
monoclonal antibody  failed to  inhibit  the  proliferative response of a  PPD-specific 
colony and  a  GAT-specific clone, which  both  utilize  the flA-aA  Ia  molecule as  a 
restriction  element.  The  result  with  the  PPD  colony was  particularly  interesting, 
because we  had  previously demonstrated  that  Y-17  could inhibit  ~20-30%  of the 
proliferative response to PPD of whole T  cell populations from B 10.A(5R)  (26). The 
failure to inhibit the response of the PPD-specific colony at all supports our original 
conclusion that  the whole population contains a  mixture of clones, some of which 
recognize  PPD  in  association  with  only •A-aA  Ia  molecules  and  some  of which 
recognize PPD in association with only flAZ-aS Ia molecules. 
Overall, the blocking studies presented here completely eliminate the possiblity that 
suppressor T  cells can account for the inhibitory effects seen with anti-Ia antibodies. 
Previous studies utilizing radiation-induced bone marrow chimeras and monoclonal 
antibodies have just as clearly shown that the site of action of these antibodies is the 
antigen-presenting cell and not the responding T  lymphocyte (40).  Thus, it appears 
that  the  most  reasonable  hypothesis  to  explain  the  inhibitory  effects  of anti-Ia 
antibodies  is  still  that  these  antibodies  mask or strip  from the  surface of antigen- 
presenting  cells  Ia  determinants  that  must  be  recognized in  conjunction with  the 
foreign antigen  in  order to stimulate  the T  cell.  The blocking with  a  monoclonal 
antibody suggests that it is the Ia-bearing molecules themselves that are essential for 
the presentation of antigen. However, the possibility ofsteric inhibition of a physically 
close, separate Ir gene product cannot be excluded. 
Summary 
The existence of T  cells specific for soluble antigens in association with unique F1 
or recombinant  major histocompatibility complex  (MHC)  gene  products was  first 
postulated from studies on the proliferative response of whole T  cell populations to 
the antigen poly(Glu~Lysa6Phea)n (Gl-zh). In this paper we use the newly developed 
technology of T  lymphocyte cloning to establish unequivocally the existence of such 
cells specific for Gl.4b and to generalize their existence by showing that Fl-specific cells 
can  be  isolated  from  T  cell  populations  primed  to  poly(Glu6°Alaa°TyrX°)n  (GAT) 
where  such  clones  represent  only  a  minor  subpopulation  of cells.  Gl.4b-primed 
B10.A(5R) and GAT-primed (B10.A ×  B10)F1 lymph node T  cells were cloned in soft 
agar, and the colonies that developed were picked and expanded in liquid culture. 
The Gl.~-specific T  cells were then recloned under conditions of high-plating effi- 
ciency to ensure that the final colonies originated from single cells. T  cells from such 
rigorously cloned populations responded  to stimulation  with  GI.@ but  only in  the 
presence  of nonimmune,  irradiated  spleen  cells  bearing  (B10.A  ×  B10)F1  or  the 
syngeneic B 10.A(5R) recombinant MHC haplotype. Spleen cells from either the B 10 
or B 10.A parental strains failed to support a proliferative response, even when added 690  FrSPECIFIC T  CELL CLONES 
together.  (B10  ×  B10.D2)F1  and  (BI0  ×  B10.RIII)F1 spleen  cells  also supported  a 
proliferative response but (B10 ×  B10.Q)Fa and (B10 X  B10.S)F1 spleen cells did not. 
These results suggested that the T  cell clones were specific for GL~ in association with 
the ~AEb-aE k'd'r' Ia molecule and that  recognition required  both gene products to be 
expressed  in  the  same  antigen-presenting  cells.  Support  for this  interpretation  was 
obtained  from inhibition  experiments  using the  monoclonal antibody Y-17 specific 
for a  determinant  on the flAS-aE Ia molecule. Y-17 completely inhibited  the prolifer- 
ative response of a  GLti~-specific clone but  had no effect on the response of either a 
PPD-specific or GAT-specific clone, both of which required the flA-Cta Ia molecule as 
their restriction element. No evidence could be found for the involvement of suppressor 
T  cells in this inhibition. We therefore conclude that the phenomenon of Frrestricted 
recognition by proliferating T  cells results from the presence of antigen-specific clones 
that must recognize unique F1 or recombinant Ia molecules on the surface of antigen- 
presenting cells in addition  to antigen in order to be stimulated. 
Received  for publication 3 November 1980. 
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